Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Prepaid Assets (2016 - 2025)

Lexaria Bioscience's Prepaid Assets history spans 11 years, with the latest figure at $850585.0 for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 91.52% year-over-year to $850585.0; the TTM value through Nov 2025 reached $850585.0, up 91.52%, while the annual FY2025 figure was $1.1 million, 4.66% down from the prior year.
  • Prepaid Assets for Q4 2025 was $850585.0 at Lexaria Bioscience, down from $1.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.2 million in Q3 2024 and bottomed at $132311.0 in Q4 2023.
  • The 5-year median for Prepaid Assets is $546783.0 (2023), against an average of $578474.5.
  • The largest annual shift saw Prepaid Assets skyrocketed 461.71% in 2021 before it crashed 71.51% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $237223.0 in 2021, then rose by 9.75% to $260342.0 in 2022, then crashed by 49.18% to $132311.0 in 2023, then skyrocketed by 235.66% to $444121.0 in 2024, then skyrocketed by 91.52% to $850585.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Prepaid Assets are $850585.0 (Q4 2025), $1.1 million (Q3 2025), and $823348.0 (Q2 2025).